ApoA-IV Monoclonal Antibody

Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon.  The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles.  Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.

Introducing the APOA-IV Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of medical research and diagnostics. This meticulously crafted antibody is specifically engineered to target and bind to the Apolipoprotein A-IV (APOA-IV) protein, offering unprecedented accuracy and precision in various applications.

The APOA-IV Monoclonal Antibody boasts an exceptional level of specificity, ensuring minimal cross-reactivity with other proteins, thus guaranteeing reliable and reproducible results. Its high affinity for APOA-IV enables efficient detection and quantification, making it an invaluable tool for researchers and clinicians alike.

This state-of-the-art antibody is meticulously manufactured using advanced techniques, resulting in a highly purified and concentrated product. Its exceptional purity and stability ensure consistent performance, allowing for prolonged storage without compromising its efficacy. Furthermore, the APOA-IV Monoclonal Antibody is rigorously quality-controlled to meet the highest industry standards, ensuring utmost reliability and reproducibility.

The versatility of the APOA-IV Monoclonal Antibody is exemplified by its wide range of applications. From fundamental research elucidating the role of APOA-IV in lipid metabolism to clinical diagnostics assessing its potential as a biomarker for various diseases, this antibody offers unparalleled insights into the intricate workings of the human body.

In summary, the APOA-IV Monoclonal Antibody represents a groundbreaking advancement in the realm of biotechnology. Its exceptional specificity, purity, and stability, coupled with its diverse applications, make it an indispensable asset for researchers and clinicians striving for excellence in their respective fields. Embrace the future of medical research and diagnostics with the APOA-IV Monoclonal Antibody.